Challenge tests in nose and bronchi: Pharmacological modulation of rhinitis and asthma

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 3, 1996, Pages 39-43

  Mygind, N ^a,c   Dahl, R ^b  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTAMINE; IPRATROPIUM BROMIDE; METHACHOLINE;

ASTHMA; COLD AIR; CONFERENCE PAPER; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RHINITIS;

ASTHMA; BRONCHI; BRONCHIAL PROVOCATION TESTS; HUMANS; NASAL PROVOCATION TESTS; NOSE; RHINITIS;

EID: 0029940422     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma. Similarities and differences. Copenhagen: Munksgaard, 1990:1-310.
2. Andersson M, Mygind N. Nasal hyperresponsiveness. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Oxford: Blackwell Science Ltd, 1995:1057-66.
3. Gerth van Wijk R. Nasal hyperreactivity: its pathogenesis and clinical significance. Clin Exp Allergy 1991; 21:661-7.
4. Godard P, Clauzel AM, Bousquet J, Michel FB. Role of allergenic bronchial challenge in the evaluation of anti-asthma drugs. Eur Respir Rev 1991; 1:25-33.
5. Weersink EJM, Postma DS, Aalbers R, deMonchy JGR. Early and late asthmatic reaction after allergen challenge. Resp Med 1994; 88:103-14.
6. Hilberg O, Jackson AC, Swift DL, Pedersen OF. Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflexes. J Appl Physiol 1989; 66:295-303.
7. Pipkorn U. Nasal provocation. Clin Rev Allergy 1988; 6:285-302.
8. 133Xe wash-out technique. Allergy 1983; 38:461-4.
9. Stewart EJ, Cinnamond MJ, Nicholls P, Stanford CF. The effect of methacholine on nasal transmucosal potential difference in normal human subjects. Rhinology 1993; 31:77-9.
10. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994; 94:1303-9.
11. Rak S, Jacobson MR, Sudderick RM et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994; 24:930-9.
12. Brofeldt S, Mygind N. Viscosity and spinability of nasal secretions. Am Rev Respir Dis 1987; 136:353-6.
13. Grønborg H, Bisgaard H, Rømeling F, Mygind N. Early and late nasal symptom response to allergen challenge. Allergy 1993; 48:87-93.
14. Konno A, Togawa K, Fujiwara T. The mechanisms involved in onset of allergic manifestations in the nose. Eur J Respir Dis 1983; 64(suppl 128):155-66.
15. Cockcroft DW. Bronchial hyperresponsiveness. In: Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma. Similarities and differences. Copenhagen: Munksgaard, 1990: 172-87.
16. Hargreave FE, Pizzichini MM, Pizzichini E. Airway hyperresponsiveness as a diagnostic feature of asthma. In: Johansson SGO, ed. Progress in Allergy and Clinical Iimmunology. Seattle: Hogrefe & Huber, 1995:63-7.
17. O'Byrne PM. Airway hyperresponsiveness. In: Elliott E, Reed CE, Adkinson NF, eds. Allergy. Principles and practice, 4th edn. St Louis: Mosby, 1993:1203-13.
18. 2 receptors in the human nose. J Allergy Clin Immunol 1982; 70:211-8.
19. Svensson C, Baumgarten C, Pipkorn U, Alkner U, Persson CGA. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax 1989; 44:13-8.
20. Grønborg H, Borum P, Mygind N. Histamine and methacholine do not increase nasal reactivity. Clin Allergy 1986; 16:597-602.
21. Walden SM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Antigen-provoked increase in histamine reactivity. Am Rev Respir Dis 1991; 144:642-8.
22. Brofeldt S, Mygind N, Sørensen CH, Marriott C. Biochemical analysis of nasal secretions induced by methacholine, histamine and allergen provocation. Am Rev Respir Dis 1986; 133:1138-42.
23. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986; 16:289-97.
24. Rajakullasingam K, Polosa R, Lau LCK. Nasal effects of bradykinin and capsaicin: influence of microvascular leakage and role of sensory neurons. J Appl Physiol 1992; 72: 1418-28.
25. Borum P. Intranasal ipratropium: inhibition of methacholine induced hypersecretion. Rhinology 1978; 16:255-33.
26. Serra-Batlles J, Montserrat JM, Mullol J et al. Response of the nose to exercise in healthy subjects and in patients with rhinitis and asthma. Thorax 1994; 49:128-32.
27. Ostberg B, Winther B, Mygind N. Cold air-induced rhinorrhoea and high-dose ipratropium. Arch Otorhinolaryngol 1987; 133:160-2.
28. Godfrey S, Bar-Yishay E. Exercise-induced asthma revisited. Respir Med 1993; 87:331-44.
29. Togias AG. Non-allergic rhinitis. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis. Clinical aspects. Copenhagen: Munksgaard, 1993:158-66.
30. Toft A, Wihl J-Å, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 1982; 12:391-401.
31. Simons FER. Antihistamines. In: Mygind N, Naclerio RM, eds. Allergic and Non-Allergic Rhinitis. Copenhagen: Munksgaard, 1993:123-36.
32. Brooks CD, Karl KJ, Francom SF. Effect of vasoconstrictor pre-treatment on obstruction, secretion and sneezing after nasal challenge with threshold and suprathreshold allergen doses. Rhinology 1993; 31:165-8.
33. Borum P, Mygind N. Inhibition of the immediate allergic reaction in the nose by beta-2 adrenergic stimulation. J Allergy Clin Immunol 1980; 66:25-32.
34. Bisgaard H, Grønborg H, Mygind N et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid. J Allergy Clin Immunol 1990; 85:891-5.
35. Dahl R, Johansson S-Å. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 1982; 63(suppl 122): 167-75.